Cross-institution positioning
Mar 27, 2026Reduction leaning. 1 reducing, 1 exited across 2 comparable institutions.
Source: Schedule 13 researchInogen Inc
Latest stored close $6.18 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 1 reducing, 1 exited across 2 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/53 non-amendment material events in the last 90 days; 1 capital-related filing/event (1 equity-related, 0 debt-related); Latest classified evidence: Material definitive agreement. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +5.5% YoY; Net income +7.3% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 1% through its reported 52-week range; -39.3% over one year.
Source: Stored historical price seriesFiled Mar 27, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Smith Kevin Raymond Merrill | AGrant, award, or other acquisition | Common Stock | 1.5K | $5.33 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Smith Kevin P. | MExercise or conversion of derivative · derivative | Restricted Stock Unit | 18.1K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Smith Kevin P. | FTax/price withholding or payment | Common Stock | 8.7K | $5.33 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Smith Kevin P. | MExercise or conversion of derivative | Common Stock | 18.1K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Smith Kevin P. | AGrant, award, or other acquisition | Common Stock | 1.5K | $5.33 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Wright Mary E | AGrant, award, or other acquisition | Common Stock | 1.5K | $5.33 | Direct | Sep 3, 2026 |
| Jul 6, 2026 | Reding Andrew P. | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 130.0K | $0.00 | Direct | Jul 9, 2026 |
| Jul 1, 2026 | Yi Boyer Jennifer M | SOpen-market or private sale | Common Stock | 10.9K | $6.60 | Direct | Jul 6, 2026 |
| Jun 5, 2026 | Sahney Mira Kirti | AGrant, award, or other acquisition | Common Stock | 28.1K | $0.00 | Direct | Jun 9, 2026 |
| Jun 5, 2026 | Jamali Vafa | AGrant, award, or other acquisition | Common Stock | 28.1K | $0.00 | Direct | Jun 9, 2026 |
| Jun 5, 2026 | Boehnlein Glenn S | AGrant, award, or other acquisition | Common Stock | 28.1K | $0.00 | Direct | Jun 9, 2026 |
| Jun 5, 2026 | Rider Heather D. | AGrant, award, or other acquisition | Common Stock | 28.1K | $0.00 | Direct | Jun 9, 2026 |
| Jun 5, 2026 | Mora Elizabeth | AGrant, award, or other acquisition | Common Stock | 28.1K | $0.00 | Direct | Jun 9, 2026 |
| Jun 5, 2026 | Ladone Mary Kay | AGrant, award, or other acquisition | Common Stock | 28.1K | $0.00 | Direct | Jun 9, 2026 |
| Jun 5, 2026 | King Kevin M | AGrant, award, or other acquisition | Common Stock | 28.1K | $0.00 | Direct | Jun 9, 2026 |
| May 29, 2026 | Yi Boyer Jennifer M | SOpen-market or private sale | Common Stock | 10.8K | $6.53 | Direct | Jun 2, 2026 |
| Apr 6, 2026 | Richardson Jason Andrew | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 100.0K | $0.00 | Direct | Apr 8, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 30, 2026 | 8-K | 1.01, 7.01, 8.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Aug 6, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 24, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jul 1, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jun 12, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jun 11, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| May 7, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 4, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Apr 6, 2026 | 8-K | 1.01, 5.02, 7.01, 9.01 | Material definitive agreement; Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Mar 30, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Feb 27, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Feb 24, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $83.5M | +5.5% |
| Ended Mar 31, 2026 | $72.4M | +5.7% |
| Ended Sep 30, 2025 | $79.1M | +5.6% |
| Ended Jun 30, 2025 | $79.2M | +6.4% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $295.3M | +5.9% |
| Ended Dec 31, 2024 | $278.8M | +10.8% |
| Ended Dec 31, 2023 | $251.6M | -21.5% |
| Ended Dec 31, 2022 | $320.5M | +2.8% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Exit below reporting threshold | 0 -1.4M | 0.00% -5.83 pts | $6.06 | $6.19 | $6.18 |
| BlackRock CIK0002012383 | Jun 30, 2025 observed Jul 17, 2025 filed · 17d Schedule 13G amendment | Reported reduction | 1.7M -81.3K | 6.20% -1.10 pts | $7.03 | $6.68 | $6.18 |
| BlackRock CIK0002012383 | Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 1.7M | $9.70 | $10.33 | $6.18 |
Compare INGN with other securities showing similar institutional activity or recent accumulation across several tracked institutions.